Showing results (281-290 of 288) with videos related to
Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 288 results.
Nature Communications|March 2, 2018
Single cell polarity in liquid phase facilitates tumour metastasisAnna Lorentzen, Paul F Becker, Jan Kosla, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2022
Clinical Models to Define Response and Survival With Anti-PD-1 Antibodies Alone or Combined With Ipilimumab in Metastatic MelanomaInês Pires da Silva, Tasnia Ahmed, Jennifer L McQuade, et al.Cancers|July 20, 2021
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Patterns of Response and Survival According to the Presence of Hepatic and Extrahepatic MetastasisElias A T Koch, Anne Petzold, Anja Wessely, et al.Nature|July 31, 2020
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanomaUgur Sahin, Petra Oehm, Evelyna Derhovanessian, et al.European Journal of Cancer (Oxford, England : 1990)|September 5, 2025
Outcome of systemic therapy in patients with advanced rare skin cancers: A retrospective multicenter DeCOG study of 209 patientsSelma Ugurel, Nessr Abu Rached, Thilo Gambichler, et al.Journal for Immunotherapy of Cancer|April 7, 2023
Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREGCindy Franklin, Peter Mohr, Leonie Bluhm, et al.Nature|July 6, 2017
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancerUgur Sahin, Evelyna Derhovanessian, Matthias Miller, et al.European Journal of Cancer (Oxford, England : 1990)|December 6, 2024
Improved survival of advanced melanoma patients receiving immunotherapy with concomitant antithrombotic therapy - A multicenter study on 2419 patients from the prospective skin cancer registry ADORegJulian Kött, Tim Zell, Noah Zimmermann, et al.Pageof 29